clonidine has been researched along with oxybutynin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 11 (84.62) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Badner, NH; Beattie, WS; Brasher, PM; Choi, PT; Delgado, DH; Dresser, GK; Wijeysundera, DN | 1 |
| Bi, H; Chen, J; Chen, X; Huang, L; Huang, M; Liao, X; Ma, Z; Pang, Y; Wang, X; Zeng, G; Zhao, X; Zhong, G; Zhuang, J | 1 |
| Hergenroeder, AC; Justino, H; Kienstra, CM; Riley, AA | 1 |
| Jiao, F; Wang, J; Zhang, X | 1 |
| Beck, B; Ehrlich, J; MacGregor, T; Marzin, K; Thiedmann, R | 1 |
| Ali Sakr Esa, W; Babazade, R; Devereaux, PJ; Gilron, I; Honar, H; Hutcherson, MT; Kurz, A; Naylor, AJ; Parlow, J; Salmasi, V; Sessler, DI; Turan, A; Zimmerman, NM | 1 |
| Guo, JM; Huang, Y; Ou, P; Qian, QF; Shi, XX; Xie, YQ; Yang, SW | 1 |
| Katas, H; Rahman, KU; Razzaq, Z; Shahid, N; Siddique, MI; Waqas, MK | 1 |
1 review(s) available for clonidine and oxybutynin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 trial(s) available for clonidine and oxybutynin
| Article | Year |
|---|---|
A randomized feasibility trial of clonidine to reduce perioperative cardiac risk in patients on chronic beta-blockade: the EPIC study.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Canada; Clonidine; Double-Blind Method; Drug Therapy, Combination; Feasibility Studies; Female; Heart Diseases; Humans; Male; Middle Aged; Pilot Projects; Postoperative Complications; Transdermal Patch; Treatment Outcome | 2014 |
Clinical observation on treatment of Tourette syndrome in Chinese children by clonidine adhesive patch.
Topics: Antipsychotic Agents; Asian People; Blood Pressure; Child; Child, Preschool; Clonidine; Female; Haloperidol; Humans; Male; Psychiatric Status Rating Scales; Tourette Syndrome; Transdermal Patch; Treatment Outcome | 2016 |
Bioequivalence and adhesion evaluation of transdermal clonidine following a change in excipient supplier.
Topics: Adhesiveness; Administration, Cutaneous; Adult; Antihypertensive Agents; Area Under Curve; Chemistry, Pharmaceutical; Clonidine; Cross-Over Studies; Double-Blind Method; Excipients; Female; Humans; Male; Middle Aged; Polyenes; Polymers; Therapeutic Equivalency; Transdermal Patch | 2016 |
Clonidine Does Not Reduce Pain or Opioid Consumption After Noncardiac Surgery.
Topics: Adrenergic alpha-2 Receptor Agonists; Aged; Analgesics; Analgesics, Opioid; Clonidine; Cross-Over Studies; Elective Surgical Procedures; Female; Humans; Male; Middle Aged; Pain Management; Pain Measurement; Pain, Postoperative; Transdermal Patch | 2016 |
[Efficacy of clonidine transdermal patch in treatment of moderate to severe tic disorders in children].
Topics: Child; Child, Preschool; Clonidine; Female; Haloperidol; Humans; Male; Severity of Illness Index; Tic Disorders; Transdermal Patch | 2017 |
7 other study(ies) available for clonidine and oxybutynin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Validation of a HPLC-ESI MS/MS method for the determination of clonidine in human plasma and its application in a bioequivalence study in Chinese healthy volunteers.
Topics: Adult; Area Under Curve; Calibration; Chromatography, High Pressure Liquid; Clonidine; Healthy Volunteers; Humans; Male; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Therapeutic Equivalency; Transdermal Patch | 2015 |
Hypertension in an Adolescent Athlete.
Topics: Adolescent; Arterial Occlusive Diseases; Athletes; Clonidine; Humans; Hypertension; Male; Time Factors; Transdermal Patch; Treatment Outcome | 2016 |
Fabrication and characterization of matrix type transdermal patches loaded with tizanidine hydrochloride: potential sustained release delivery system.
Topics: Administration, Cutaneous; Animals; Biological Availability; Clonidine; Delayed-Action Preparations; Drug Delivery Systems; Drug Liberation; Excipients; Materials Testing; Muscle Relaxants, Central; Myalgia; Polymers; Rabbits; Skin; Skin Absorption; Transdermal Patch | 2018 |